Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	18.81B
Revenue (ttm)	11.55B
Net Income (ttm)	1.04B
Shares Out	1.16B
EPS (ttm)	0.89
PE Ratio	18.23
Forward PE	14.87
Dividend	0.36 (2.16%)
Ex-Dividend Date	May 22, 2025

Volume	15,644,800
Average Volume	19,821,350
Open	15.64
Previous Close	16.50
Day's Range	15.64 - 16.75
52-Week Range	12.96 - 18.96
Beta	0.44
RSI	59.20
Earnings Date	Aug 20, 2025

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.